1205 Avenue J, Brooklyn, NY 11230 | Phone: (718) 258-6686 | Fax: (718) 258-2360 | Mon-Thu 9:00am - 9:00pm | Fri 8:00am - 5:00pm | Sat Closed | Sun 9:00am - 6:00pm
Manténgase sano!
- Posted December 16, 2025
Is Tamoxifen Alone a Viable Option for Women with Low-Risk DCIS Breast Cancer?
In a new study, women with very early-stage DCIS breast cancer taking tamoxifen alone had higher recurrence rates than researchers expected. But they say the incidence of invasive breast cancer was still low at 5 years, suggesting tamoxifen alone may be an option in “carefully selected patients.”
